Jawad Haider Butt, MD, PhD

Jawad Haider Butt, MD, PhD, Glasgow Cardiovascular Research Center, University of Glasgow, Glasgow, United Kingdom.

Articles by Jawad Haider Butt, MD, PhD

High-Impact Trials at ACC.25 Signal Shift in Chronic Disease Treatment

ByGiuliana Grossi,Christian Ruff, MD,John Buse, MD, PhD,Marc P. Bonaca, MD, MPH,Marc Humbert, MD, PhD,Jawad Haider Butt, MD, PhD,Siddharth M. Patel, MD, MPH

April 4th 2025

Experts highlight groundbreaking research presented at the American College of Cardiology Annual Scientific Session (ACC.25), which emphasized a shift toward more personalized, evidence-based treatment strategies.

FINEARTS-HF Data Examine Finerenone Across Bilirubin Levels: Jawad Haider Butt, MD, PhD

ByGiuliana Grossi,Jawad Haider Butt, MD, PhD

April 2nd 2025

Findings presented at the American College of Cardiology Annual Scientific Session indicate that finerenone's efficacy in reducing cardiovascular death did not significantly differ across baseline bilirubin tertiles.

Jawad Haider Butt, MD, PhD

Articles by Jawad Haider Butt, MD, PhD

High-Impact Trials at ACC.25 Signal Shift in Chronic Disease Treatment

FINEARTS-HF Data Examine Finerenone Across Bilirubin Levels: Jawad Haider Butt, MD, PhD

Latest Updated Articles

Trending on AJMC

EHA 2026 Late Breakers Deliver Practice-Shifting Phase 3 Data and Novel CAR T Approaches Across Hematology

Paul Richardson, MD, Calls Mezigdomide “CAR T in a Pill” for Patients With R/R Multiple Myeloma

MRD-Guided CLL Treatment Duration: Personalization or Malpractice?

Type 5 Diabetes: A Long-Ignored Condition Gets Its Moment

Teclistamab Outperforms Len/Dex in High-Risk Smoldering Myeloma With Higher CR Rate, PFS: Omar Nadeem, MD